Filing Details
- Accession Number:
- 0001209191-20-032329
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-27 17:00:12
- Reporting Period:
- 2020-05-26
- Accepted Time:
- 2020-05-27 17:00:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492426 | Horizon Therapeutics Public Ltd Co | HZNP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1667903 | M. Geoffrey Curtis | C/O Horizon Therapeutics Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | Evp, Corporate Affairs, Cco | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2020-05-13 | 5,720 | $0.00 | 56,752 | No | 5 | G | Direct | |
Ordinary Shares | Disposition | 2020-05-26 | 21,918 | $49.85 | 34,834 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 420 | Indirect | By spouse |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020.